Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Isohypericin
Potential treatment - theoretical effect Natural product Antiviral Mar/02/2021
Breast milk
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021
S-Trimer
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/01/2021
Cefuroxime
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/01/2021
Cefotaxime
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/01/2021
Ceftriaxone
Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/01/2021
ΔABP-α2
Potential treatment - theoretical effect Experimental Antiviral Mar/01/2021
Calpain inhibitor II
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Boceprevir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Calpain inhibitor XII
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Flupirtine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Qing Fei Pai Du Tang
Potential treatment - clinical evidence Natural product Antiviral Feb/28/2021
Ginkgolic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/28/2021
Saikosaponin B2
Potential treatment - theoretical effect Natural product Antiviral Feb/26/2021
W4P-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021
Azithromycin
Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021
Ascorbic acid
Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021
Cleistanthin B
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/25/2021
Diphyllin
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/25/2021
1212C2
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021